India’s COVID-19 vaccine produced by Bharat Biotech has shown an interim vaccine efficacy of 81 percent in late-stage clinical trials .The interim analysis was based on 43 recorded cases of COVID-19 in the trial of 25,800 participants, conducted in partnership with the Indian Council of Medical Research (ICMR) – India’s premier medical research body.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Velit omnis animi et iure laudantium vitae, praesentium optio, sapiente distinctio illo?